drugset / Trial / NCT04062357
Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aimed to appraise effectiveness and tolerability of lidocaine 5% spray in treatment of patients with premature ejaculation (PE). The current study has been designed as a randomized single-blind placebo-controlled clinical trial. It was done on 150 lifelong PE patients with normal erection. They were randomized evenly categorized into two treatment groups. Group 1 (n₌75); was given on demand lidocaine 5% spray for 8 weeks. Group 2 (n₌75); was given placebo in form on demand alcohol spray for 8 weeks.
Timeline
- Start
- 2018-04-20
- Primary completion
- 2019-01-20
- Completion
- 2019-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 5 mg | Topical |
| Comparator | Lidocaine | Other / unclassified | 10 mg | Topical |
Indications
No indication recorded.